OpenTrust to secure wireless network access for 4,000 iPhone, iPad users of global pharma company

OpenTrust, the Next-Gen IT security software publisher, today announced that it will secure wireless network access for users of 4,000 iPhones and iPads for a leading global organization.

The customer is a global pharmaceutical company with a broad portfolio of pharmaceutical products and presence across both traditional and emerging markets. It has more than 100,000 employees in over 100 countries.

The project will provide secure remote access to the corporate network for the growing number of iPhone and iPad users thus significantly reducing roaming costs for remotely located employees. The potential demand for this service is expected to grow exponentially over the coming months.

OpenTrust's innovate Mobile technology establishes unquestionable trust between the IT infrastructure, the mobile device itself and the user, authenticating the devices and the users to the corporate network.

OpenTrust Mobile is rapidly and seamlessly integrated within the existing corporate IT infrastructure for a low TCO solution. OpenTrust Mobile turns iPhones and iPads into Trusted Devices, used by Trusted users and managed using OpenTrust Digital Identities. In addition to iPad and iPhone, OpenTrust Mobile supports other popular Mobile OS including BlackBerry and Windows.

"iPhones and iPads are proving to be extremely valuable business tools. IT departments are now obliged to find ways to securely connect such devices to the enterprise network. OpenTrust Mobile allows customers to manage digital identities held on mobile devices including iPhone and iPad so that users can remotely and automatically authenticate themselves to corporate networks". said Olivier Guilbert, CEO of OpenTrust.

SOURCE OpenTrust 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
American Heart Association expands Cardiovascular-Kidney-Metabolic Health Initiative to 15 regions